Concentration is how strong your mixed vial is in mcg per mL
Click here for more details
Use of the peptide Ac-Nle-cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH for the manufacture of a medicament for use in the treatment by multiple agent therapy with a PDE-5 inhibitor for the treatment sexual dysfunction, wherein the amount of each of the peptide Ac-Nle- cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH and the PDE-5 inhibitor is not sufficient, if administered as monotherapy, to independently initiate the desired pharmacological response in the patient
Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS: Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects
Furthermore, we found that the activity of ERK1/2 was negatively regulated by AMPK in vitro
Specifically, the concentration and timing of drug administration significantly impact therapeutic responses